Has Yelena Tumashova, MD received payments from drug or device companies?

Yes. Drug and device makers reported $59,207 in general payments to Yelena Tumashova, MD across 233 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yelena Tumashova, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yelena Tumashova, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yelena Tumashova, MD

Neurology · Des Plaines, ILNPI 1720066210

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 57.3% of the total. Reporting peaked in 2023 at $28,045 and has fallen 96.9% since, to $862 in 2025. Among neurology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,207in general payments, 2019–2025

Across 233 payments — averaging $254.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$34K
Pfizer$12K
Itamar Medical Inc$6K
Livanova USA, Inc.$2K
Sanofi$1K
Lilly USA, LLC$528
plus $4K from 20 others

What the payments were for

Consulting fees$28,38348%
Speaking & faculty fees$2,0003%
Travel & lodging$4,5218%
Food & beverage$24,12141%
Education$1820%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	63	$33,942
Pfizer	2	$11,500
Itamar Medical Inc	3	$5,997
Livanova USA, Inc.	22	$2,248
Sanofi	14	$1,225
Lilly USA, LLC	19	$528
Genentech USA, Inc.	13	$503
Jazz Pharmaceuticals Inc.	19	$478
Teva Pharmaceuticals USA, Inc.	27	$393
Mallinckrodt Hospital Products Inc.	3	$383
Novo Nordisk	5	$269
EMD Serono, Inc.	5	$268
UCB, Inc.	13	$249
Abbott	2	$211
Harmony Biosciences LLC	2	$176
Novartis	6	$157
Biohaven Pharmaceuticals, Inc.	1	$136
MDD US Operations, LLC	1	$122
Bristol Myers Squibb	1	$117
E.r. Squibb & Sons, L.L.C.	1	$111
AbbVie(2 entities)	3	$48
Avadel CNS Pharmaceuticals, LLC	2	$46
Supernus Pharmaceuticals, Inc.	2	$34
Biogen	2	$28
Resmed Corp	1	$22
GSK	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$21,957
ELIQUIS$11,500
Inspire$10,700
WatchPATONE$5,997
VNS Therapy$1,361
AUBAGIO$949
OCREVUS$411
ACTHAR$383
AJOVY$253
ZEPOSIA$228
VNS - Sentiva$217
NURTEC ODT$136
Infinity DBS Pulse Generators$124
APOKYN$122
Wegovy$119
Mavenclad$110

How this compares

$59,207 in reported general payments places this provider in the 90th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois →

Medicare billing

Part B allowed, 2024

$52,685

Medicare patients

614

Services billed

709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Des Plaines

Augusto MiravalleChicago$1.4M
Lori GuytonHerrin$1.1M
Daniel WynnNorthbrook$812K
Arthur ItkinPalos Heights$808K
Andrew GordonLake Barrington$765K
Martha McGrawWinfield$625K
Reuben ValenzuelaPeoria$590K
Adil JavedChicago$584K
Tyler KaplanMaywood$549K
Danny BegaChicago$442K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →